-
Mashup Score: 3ASTCT Supports the FDA’s Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma - 19 day(s) ago
The Food and Drug Administration approves CAR T-Cell therapy Abecma as a second-line treatment and the CAR T-Cell therapy Carvykti as a third-line treatment for multiple myeloma.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9ASTCT Supports the FDA’s Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma - 23 day(s) ago
The Food and Drug Administration approves CAR T-Cell therapy Abecma as a second-line treatment and the CAR T-Cell therapy Carvykti as a third-line treatment for multiple myeloma.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation - 1 month(s) ago
The Centers for Medicare & Medicaid Services revise the National Coverage Determination of allogeneic hematopoietic stem cell transplantation (HSCT) for individuals with myelodysplastic syndromes (MDS) based on requests from ASH, ASTCT, NMDP, and CIBMTR.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1ASCP Partners With the Lamy Center at the University of Maryland School of Pharmacy to Spread the Adoption of Age-Friendly Health Systems - 2 month(s) ago
As the older adult population continues to grow exponentially, the American Society of Consultant Pharmacists (ASCP) and The Peter Lamy Center on …
Source: www.newswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12American Society for Transplantation and Cellular Therapy Awards Robin Roberts With the 2024 Public Service Award - 3 month(s) ago
The annual award honors Roberts’ special service to the patients and families that are served by the ASTCT community.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0American Society for Transplantation and Cellular Therapy Awards Robin Roberts With the 2024 Public Service Award - 3 month(s) ago
The annual award honors Roberts’ special service to the patients and families that are served by the ASTCT community.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3ASTCT, AACI, and ACCC Launch RECUR Initiative to Enhance Patient Access to CAR T Therapy - 3 month(s) ago
The American Society for Transplantation and Cellular Therapy (ASTCT), the Association of American Cancer Institutes (AACI), and the Association …
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet-
ASTCT, @AACI_Cancer & @ACCCBuzz recently launched the RECUR Initiative. This collaboration aims to revolutionize the evaluation process for #CART therapy by focusing on five crucial factors to ensure timely & personalized care. Read the full press release: https://t.co/QggbLeXD84 https://t.co/sbyk9tTRgP
-
-
Mashup Score: 14ASTCT Response to FDA Approval of Gene Therapies for Treatment of Sickle Cell Disease (SCD) - 5 month(s) ago
The American Society for Transplantation and Cellular Therapy® (ASTCT®) recognizes the US Food and Drug Administration’s (FDA) recently granted a …
Source: www.newswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 14ASTCT Response to FDA Approval of Gene Therapies for Treatment of Sickle Cell Disease (SCD) - 5 month(s) ago
The American Society for Transplantation and Cellular Therapy® (ASTCT®) recognizes the US Food and Drug Administration’s (FDA) recently granted a …
Source: www.newswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0L-Nutra Launches Revolutionary Healthcare Program for Diabetes Remission - 11 month(s) ago
L-Nutra, a leading company in the field of Longevity and Food as Medicine, is delighted to announce the launch of its groundbreaking program, L-N …
Source: www.newswire.comCategories: Latest Headlines, Partners & KOLsTweet
ASTCT supports the decision by the @US_FDA to grant #multiplemyeloma patients earlier access to two #CARTcell therapies. This approval allows for greater access to life-saving treatments. Read the press release: https://t.co/3erfnEdOzy #MMsm https://t.co/avTkUWgQ5T